Stay updated on Avutometinib and Defactinib in Thyroid Cancer Clinical Trial
Sign up to get notified when there's something new on the Avutometinib and Defactinib in Thyroid Cancer Clinical Trial page.

Latest updates to the Avutometinib and Defactinib in Thyroid Cancer Clinical Trial page
- Check3 days agoChange DetectedAn updated study overview was added, detailing the evaluation of avutometinib and defactinib for RAF dimer-driven thyroid cancers and the safety profile. The FDA OOPD funding line was added, and the previous version of the description and its revision notes was removed.SummaryDifference0.3%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedNew quick links were added to the Study Details page (Check who can join, Find Contact Information, How to Read a Study Record, Common Questions, How to Join a Study), and the label for Intervention/Treatment was adjusted. The version tag was updated from v3.5.5 to v3.6.0.SummaryDifference0.5%

- Check24 days agoChange DetectedThe page revision label was updated from v3.5.4 to v3.5.5. This reflects a minor update to the published page without altering the study content.SummaryDifference0.1%

- Check46 days agoChange DetectedThe page's revision line changed from v3.5.3 to v3.5.4, indicating a new release of the page content. This update reflects a metadata or maintenance release rather than a substantive change to the page's information.SummaryDifference0.1%

- Check67 days agoChange DetectedThis update refreshes the website’s version/revision footer from v3.5.2 to v3.5.3 without changing the study record content.SummaryDifference0.1%

- Check74 days agoChange DetectedThe website revision was updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

Stay in the know with updates to Avutometinib and Defactinib in Thyroid Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avutometinib and Defactinib in Thyroid Cancer Clinical Trial page.